{"hands_on_practices": [{"introduction": "Mastering the logic of gene regulation often begins with understanding the distinct roles of activators and repressors. This practice problem is a classic exercise that allows you to dissect the *lac* operon's control system by comparing two key mutations. By predicting the expression of β-galactosidase in strains lacking either the LacI repressor or the CAP activator, you'll gain a firm grasp on how negative and positive control mechanisms work together to fine-tune gene expression in response to environmental cues. [@problem_id:1473438]", "problem": "The *lac* operon in *Escherichia coli* is a canonical system for studying gene regulation. It comprises a set of genes required for lactose metabolism, including `lacZ`, which encodes the enzyme β-galactosidase. The expression of this operon is tightly controlled by the availability of sugars in the environment.\n\nTwo key regulatory genes are involved:\n1.  The `lacI` gene, which is located outside the operon, codes for the LacI repressor protein. In the absence of lactose, the LacI protein binds to a region of the operon called the operator, physically blocking transcription. When lactose is present, it is converted to allolactose, which binds to the LacI protein and prevents it from binding to the operator.\n2.  The `crp` gene codes for the Catabolite Activator Protein (CAP). This protein acts as an activator. When glucose levels in the cell are low, CAP binds to a signaling molecule and then to a site near the operon's promoter, significantly enhancing the rate of transcription. When glucose levels are high, CAP remains inactive and does not bind to the DNA.\n\nConsider two different mutant strains of *E. coli*:\n-   **Strain 1:** A `crp-` mutant, which has a loss-of-function mutation in the `crp` gene and cannot produce a functional CAP protein.\n-   **Strain 2:** A `lacI-` mutant, which has a loss-of-function mutation in the `lacI` gene and cannot produce a functional LacI repressor protein.\n\nFor each mutant, predict the level of β-galactosidase expression when grown in four different media. The possible expression levels are \"None\", \"Basal\" (a very low, leaky level of transcription), and \"High\" (fully activated transcription).\n\nWhich of the following tables correctly predicts the expression pattern for both strains across all conditions?\n\n**A.**\n| Strain | Medium (+/- indicates presence/absence) | Expression Level |\n| :--- | :--- | :--- |\n| `crp-` | + Glucose, - Lactose | None |\n| `crp-` | + Glucose, + Lactose | Basal |\n| `crp-` | - Glucose, - Lactose | None |\n| `crp-` | - Glucose, + Lactose | Basal |\n| `lacI-`| + Glucose, - Lactose | Basal |\n| `lacI-`| + Glucose, + Lactose | Basal |\n| `lacI-`| - Glucose, - Lactose | High |\n| `lacI-`| - Glucose, + Lactose | High |\n\n**B.**\n| Strain | Medium (+/- indicates presence/absence) | Expression Level |\n| :--- | :--- | :--- |\n| `crp-` | + Glucose, - Lactose | Basal |\n| `crp-` | + Glucose, + Lactose | Basal |\n| `crp-` | - Glucose, - Lactose | High |\n| `crp-` | - Glucose, + Lactose | High |\n| `lacI-`| + Glucose, - Lactose | None |\n| `lacI-`| + Glucose, + Lactose | Basal |\n| `lacI-`| - Glucose, - Lactose | None |\n| `lacI-`| - Glucose, + Lactose | Basal |\n\n**C.**\n| Strain | Medium (+/- indicates presence/absence) | Expression Level |\n| :--- | :--- | :--- |\n| `crp-` | + Glucose, - Lactose | None |\n| `crp-` | + Glucose, + Lactose | None |\n| `crp-` | - Glucose, - Lactose | None |\n| `crp-` | - Glucose, + Lactose | None |\n| `lacI-`| + Glucose, - Lactose | High |\n| `lacI-`| + Glucose, + Lactose | High |\n| `lacI-`| - Glucose, - Lactose | High |\n| `lacI-`| - Glucose, + Lactose | High |\n\n**D.**\n| Strain | Medium (+/- indicates presence/absence) | Expression Level |\n| :--- | :--- | :--- |\n| `crp-` | + Glucose, - Lactose | None |\n| `crp-` | + Glucose, + Lactose | Basal |\n| `crp-` | - Glucose, - Lactose | None |\n| `crp-` | - Glucose, + Lactose | High |\n| `lacI-`| + Glucose, - Lactose | Basal |\n| `lacI-`| + Glucose, + Lactose | Basal |\n| `lacI-`| - Glucose, - Lactose | None |\n| `lacI-`| - Glucose, + Lactose | High |\n\n**E.**\n| Strain | Medium (+/- indicates presence/absence) | Expression Level |\n| :--- | :--- | :--- |\n| `crp-` | + Glucose, - Lactose | None |\n| `crp-` | + Glucose, + Lactose | Basal |\n| `crp-` | - Glucose, - Lactose | None |\n| `crp-` | - Glucose, + Lactose | Basal |\n| `lacI-`| + Glucose, - Lactose | None |\n| `lacI-`| + Glucose, + Lactose | Basal |\n| `lacI-`| - Glucose, - Lactose | None |\n| `lacI-`| - Glucose, + Lactose | High |", "solution": "Key regulatory logic for the lac operon:\n- The LacI repressor binds the operator and blocks transcription when lactose is absent. When lactose is present, it is converted to allolactose, which inactivates LacI so the repressor does not bind.\n- The CAP activator enhances transcription only when glucose is low; this requires functional CRP (the product of the crp gene). When glucose is high, CAP is inactive and does not enhance transcription.\n- Therefore:\n  - If the repressor is bound (no lactose and functional LacI), expression is None.\n  - If the repressor is not bound but CAP is inactive (high glucose or no functional CRP), expression is Basal.\n  - If the repressor is not bound and CAP is active (low glucose and functional CRP), expression is High.\n\nApply this to each mutant.\n\nStrain 1: crp- (loss of functional CAP)\n- CAP activation cannot occur regardless of glucose. Thus High expression is impossible.\n- If lactose is absent, the repressor binds and expression is None.\n- If lactose is present, the repressor is off, but without CAP activation the expression is Basal.\n- Hence:\n  - + Glucose, - Lactose: None\n  - + Glucose, + Lactose: Basal\n  - - Glucose, - Lactose: None\n  - - Glucose, + Lactose: Basal\n\nStrain 2: lacI- (loss of functional repressor)\n- The repressor is never bound regardless of lactose, so repression is absent in all conditions.\n- Expression level depends only on CAP:\n  - With high glucose, CAP is inactive, giving Basal expression.\n  - With low glucose, CAP is active (assuming CRP is functional), giving High expression.\n- Lactose presence is irrelevant in this mutant.\n- Hence:\n  - + Glucose, - Lactose: Basal\n  - + Glucose, + Lactose: Basal\n  - - Glucose, - Lactose: High\n  - - Glucose, + Lactose: High\n\nComparing these predictions with the options, only option A matches both strains across all conditions.", "answer": "$$\\boxed{A}$$", "id": "1473438"}, {"introduction": "Building on the foundational roles of repressors and activators, we now explore how these molecular mechanisms translate into observable population-level behavior, such as the classic diauxic growth curve. This scenario presents a thought experiment involving a specific mutation that disables \"inducer exclusion\" without affecting the core CAP-cAMP activation circuit. By analyzing how this change alters the transition from glucose to lactose metabolism, you will uncover the subtle but crucial role of inducer exclusion in enforcing metabolic hierarchy and shaping bacterial growth dynamics. [@problem_id:1473460]", "problem": "In the study of bacterial gene regulation, the diauxic growth curve is a classic example of metabolic preference. Consider a laboratory experiment where a wild-type strain of *Escherichia coli* is cultured in a minimal medium containing equal molar concentrations of both glucose and lactose. This strain exhibits a typical diauxic growth pattern.\n\nNow, consider a mutant strain of *E. coli*. This particular mutant has a loss-of-function mutation in the gene encoding the Enzyme IIA component of the phosphotransferase system (PTS). This specific mutation completely disables the mechanism of \"inducer exclusion\" without affecting any other cellular processes. The regulatory systems involving the `lac` repressor protein (LacI) and the Catabolite Activator Protein (CAP) in conjunction with cyclic AMP (cAMP) are both fully intact and functional.\n\nIf this mutant strain is grown in the same medium (containing both glucose and lactose), how will its growth curve (log of cell number versus time) differ from the wild-type strain?\n\nSelect the option that best describes the expected outcome.\n\nA. The mutant will exhibit a single, continuous logarithmic growth phase, as it will metabolize both glucose and lactose simultaneously from the beginning of the experiment.\n\nB. The mutant will exhibit a classic diauxic growth curve that is indistinguishable from the wild-type strain, with two distinct growth phases separated by a noticeable lag phase.\n\nC. The mutant will show growth on glucose first, followed by growth on lactose, but the lag phase between the two growth periods will be significantly shorter than that observed in the wild-type strain.\n\nD. The mutant will grow only on glucose and will be unable to utilize lactose, resulting in a single growth phase followed by an early entry into the stationary phase.\n\nE. The mutant will exhibit a reversed diauxic growth pattern, prioritizing the metabolism of lactose first before switching to glucose.", "solution": "To determine the growth pattern of the mutant strain, we must analyze the two primary layers of regulation of the *lac* operon in the presence of glucose: positive control by the Catabolite Activator Protein (CAP)-cAMP complex and repression via inducer exclusion.\n\nFirst, let's review the regulation in a wild-type *E. coli* cell in a medium containing both glucose and lactose, which leads to the classic diauxic growth curve.\n1.  **Phase 1: Glucose Metabolism.** Glucose is the preferred carbon source. Its transport into the cell via the phosphotransferase system (PTS) has two major regulatory consequences. First, it inhibits the enzyme adenylyl cyclase, leading to low intracellular levels of cyclic AMP (cAMP). Without cAMP, CAP cannot bind to the *lac* promoter, and transcription of the *lac* operon is not activated. This is the positive control aspect. Second, the unphosphorylated form of the PTS protein EIIA^Glc accumulates and directly inhibits the activity of lactose permease (LacY). This is inducer exclusion. It prevents lactose from entering the cell, so no allolactose can be synthesized to inactivate the LacI repressor. The *lac* operon is therefore doubly repressed: the activator (CAP) is absent and the repressor (LacI) is bound. The cell grows exclusively on glucose.\n2.  **Lag Phase.** Once glucose is exhausted, the inhibitory effects are lifted. Adenylyl cyclase becomes active, cAMP levels rise, and CAP-cAMP complexes form. Inducer exclusion ceases, allowing lactose to enter the cell via the few permease molecules that are present due to basal expression. Lactose is converted to allolactose, which then binds to and inactivates the LacI repressor. The lag phase represents the time required for these molecular rearrangements to occur and for the cell to synthesize sufficient quantities of lactose permease and β-galactosidase to begin metabolizing lactose efficiently.\n3.  **Phase 2: Lactose Metabolism.** With the LacI repressor removed and the CAP-cAMP complex bound, the *lac* operon is fully induced. The cell synthesizes the necessary enzymes and grows by metabolizing lactose.\n\nNow, let's consider the specified mutant. The mutation disables inducer exclusion, but the CAP-cAMP system remains functional.\n1.  **Phase 1: Glucose Present.** Glucose is present, so it is transported into the cell. As in the wild-type, this leads to low intracellular cAMP levels, and the CAP protein remains inactive. However, the crucial difference is that inducer exclusion is disabled. Therefore, lactose permease (LacY) is active, and lactose is transported into the cell from the very beginning. Inside the cell, lactose is converted to allolactose, which inactivates the LacI repressor, causing it to detach from the operator region of the *lac* operon. In this state, the operon is no longer repressed by LacI, but it is also not activated by CAP. This results in a low level of transcription—higher than the basal level of a fully repressed operon, but much lower than the fully activated level. The cell will produce a small number of *lac* enzymes while primarily growing on glucose.\n2.  **Transition (Lag Phase).** As soon as the glucose is depleted, the inhibition of adenylyl cyclase is lifted. Intracellular cAMP levels rise rapidly. CAP-cAMP complexes form and can immediately bind to the *lac* promoter to strongly activate transcription. Since the LacI repressor is already inactivated by allolactose (which has been present all along) and a small pool of lactose-metabolizing enzymes already exists, the switch to full lactose metabolism can occur almost instantaneously. The time needed to induce the operon is drastically reduced compared to the wild-type, which had to start from a state of double repression. Consequently, the lag phase is significantly shortened or may be practically absent.\n3.  **Phase 2: Lactose Present.** The *lac* operon is now fully activated, and the cell grows on lactose, just as in the wild-type.\n\nBased on this analysis, the mutant will still show two distinct growth phases because the CAP-cAMP system ensures glucose is used first. However, the transition between these phases will be much faster.\n\nEvaluating the options:\nA. Incorrect. The CAP-cAMP system still enforces preferential use of glucose, so simultaneous metabolism at maximal rates does not happen.\nB. Incorrect. The mutation eliminates one of the two key repressive mechanisms active during glucose metabolism, which must have an effect on the transition.\nC. Correct. The mutant first consumes glucose. The lag phase is significantly shorter because the *lac* operon is already derepressed (LacI is inactive) and only awaits CAP activation, which occurs as soon as glucose is depleted.\nD. Incorrect. The *lac* operon machinery is entirely functional; the cell is perfectly capable of using lactose once glucose is gone.\nE. Incorrect. The CAP-cAMP system ensures glucose preference, a fundamental aspect of catabolite repression that is intact in the mutant.", "answer": "$$\\boxed{C}$$", "id": "1473460"}, {"introduction": "The principles of catabolite repression are not just for understanding natural systems; they are powerful tools for engineering new biological functions. This final practice moves from analysis to synthesis, challenging you to design a synthetic gene circuit that produces a specific output—peak protein expression at an intermediate glucose level. By applying concepts of regulatory protein concentration, dimerization, and competitive binding, you will see how fundamental knowledge from microbial physiology can be harnessed to create sophisticated biosensors and other synthetic biology devices. [@problem_id:2057641]", "problem": "A synthetic biologist is designing a gene circuit in *Escherichia coli* to function as a biosensor. The goal is to have the expression of a target protein, P, be maximal at a specific, intermediate concentration of glucose in the growth medium. The circuit is designed with the following components and interactions:\n\n1.  A regulatory protein, A, is produced by the cell. Its total steady-state concentration, $[A]_{total}$, is inversely dependent on the extracellular glucose concentration, $[G]$, due to the mechanism of catabolite repression. This relationship is modeled by the equation:\n    $$[A]_{total} = \\frac{k_A}{K_G + [G]}$$\n    where $k_A$ is a lumped parameter representing the maximum production and stability of protein A, and $K_G$ is a constant related to glucose transport and metabolism.\n\n2.  Protein A regulates the expression of the target protein P. Protein A exists in a monomer-dimer equilibrium described by the reaction $2A \\rightleftharpoons A_2$, with a dissociation constant $K_D = \\frac{[A]^2}{[A_2]}$, where $[A]$ and $[A_2]$ are the concentrations of the monomer and dimer, respectively.\n\n3.  The Promoter for protein P is engineered to be regulated by both the monomer and the dimer of protein A. The monomer, A, acts as a transcriptional activator, while the dimer, $A_2$, acts as a transcriptional repressor.\n\n4.  The production rate of protein P, denoted as $R_P$, is described by the following equation, which accounts for competitive binding of the activator and repressor:\n    $$R_P = V_{max} \\frac{\\frac{[A]}{K_{act}}}{1 + \\frac{[A]}{K_{act}} + \\frac{[A_2]}{K_{rep}}}$$\n    where $V_{max}$ is the maximum possible production rate, $K_{act}$ is the activation constant for the monomer, and $K_{rep}$ is the repression constant for the dimer.\n\nFor the purpose of this analysis, you may make a simplifying assumption that the vast majority of the total protein A exists in the monomeric form. This allows the monomer concentration $[A]$ to be approximated by the total concentration, $[A] \\approx [A]_{total}$. The dimer concentration, $[A_2]$, is then determined by the equilibrium with this monomer pool.\n\nYour task is to determine the optimal extracellular glucose concentration, $[G]_{opt}$, that results in the maximum production rate of protein P. Derive a closed-form analytic expression for $[G]_{opt}$ in terms of the given parameters: $k_A$, $K_G$, $K_D$, $K_{act}$, and $K_{rep}$.", "solution": "The total steady-state concentration of A as a function of extracellular glucose is modeled as $[A]_{total} = \\frac{k_A}{K_G + [G]}$. Under the simplifying assumption that the monomer dominates, set $[A] \\approx [A]_{total}$ and denote $a \\equiv [A] = \\frac{k_A}{K_G + [G]}$. The dimer concentration follows from the monomer-dimer equilibrium $2A \\rightleftharpoons A_2$ with $K_D = \\frac{[A]^{2}}{[A_2]}$, yielding $[A_2] = \\frac{a^{2}}{K_D}$.\n\nThe production rate of P is\n$$\nR_P = V_{max} \\frac{\\frac{a}{K_{act}}}{1 + \\frac{a}{K_{act}} + \\frac{[A_2]}{K_{rep}}}\n= V_{max} \\frac{\\frac{a}{K_{act}}}{1 + \\frac{a}{K_{act}} + \\frac{a^{2}}{K_D K_{rep}}}.\n$$\nTo maximize $R_P$ with respect to $[G]$, use the chain rule with $a([G])$:\n$$\n\\frac{dR_P}{d[G]} = \\frac{dR_P}{da} \\frac{da}{d[G]}.\n$$\nSince $a([G]) = \\frac{k_A}{K_G + [G]}$, its derivative is\n$$\n\\frac{da}{d[G]} = -\\frac{k_A}{(K_G + [G])^{2}} \\neq 0,\n$$\nso the stationary points satisfy $\\frac{dR_P}{da} = 0$.\n\nDefine $f(a) = \\frac{\\frac{a}{K_{act}}}{1 + \\frac{a}{K_{act}} + \\frac{a^{2}}{K_D K_{rep}}}$. Let $\\alpha \\equiv \\frac{1}{K_{act}}$ and $\\beta \\equiv \\frac{1}{K_D K_{rep}}$. Then\n$$\nf(a) = \\frac{\\alpha a}{1 + \\alpha a + \\beta a^{2}}.\n$$\nDifferentiate using the quotient rule:\n$$\n\\frac{df}{da} = \\frac{\\alpha(1 + \\alpha a + \\beta a^{2}) - \\alpha a(\\alpha + 2\\beta a)}{(1 + \\alpha a + \\beta a^{2})^{2}}\n= \\frac{\\alpha\\left[1 + \\alpha a + \\beta a^{2} - \\alpha a - 2\\beta a^{2}\\right]}{(1 + \\alpha a + \\beta a^{2})^{2}}\n= \\frac{\\alpha\\left[1 - \\beta a^{2}\\right]}{(1 + \\alpha a + \\beta a^{2})^{2}}.\n$$\nSetting $\\frac{df}{da} = 0$ yields\n$$\n1 - \\beta a^{2} = 0 \\quad \\Rightarrow \\quad a^{2} = \\frac{1}{\\beta} = K_D K_{rep}.\n$$\nConcentrations are nonnegative, so the physically relevant optimizer is\n$$\na_{opt} = \\sqrt{K_D K_{rep}}.\n$$\nRelate this to $[G]$ via $a = \\frac{k_A}{K_G + [G]}$:\n$$\n\\sqrt{K_D K_{rep}} = \\frac{k_A}{K_G + [G]_{opt}}\n\\quad \\Rightarrow \\quad\nK_G + [G]_{opt} = \\frac{k_A}{\\sqrt{K_D K_{rep}}}\n\\quad \\Rightarrow \\quad\n[G]_{opt} = \\frac{k_A}{\\sqrt{K_D K_{rep}}} - K_G.\n$$\nThis closed-form expression is independent of $K_{act}$, which cancels in the optimization condition.", "answer": "$$\\boxed{\\frac{k_A}{\\sqrt{K_D K_{rep}}} - K_G}$$", "id": "2057641"}]}